Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection

NCT05010577 is registered in ClinicalTrials.gov with BiomX, Inc. as lead sponsor.

NCT NCT05010577
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05010577 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b/2a, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Nebulized Bacteriophage Treatment in Outpatient Adult Cystic Fibrosis (CF) Subjects With Chronic Pseudomonas Aeruginosa (PsA) Pulmonary Infection
Lead sponsor
BiomX, Inc.
Phase
Phase 1/2
Overall status
Completed
Start date
June 21, 2022
Completion date
March 10, 2024
Enrollment
43 (actual)
Sites
28

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pseudomonas aeruginosa infection, cystic fibrosis